How to Measure the Underlying Health of a Business

A company can report excellent earnings and still be sick. It can show a growing stock price while its fundamental health deteriorates. Reported net income is one of the most carefully managed numbers in corporate finance—and one of the least reliable signals of whether a business is genuinely strong.

The best investors learn to read beneath the headline numbers. They track four business health metrics that are harder to manipulate and more revealing of long-term quality: organic revenue growth, gross margin trend, free cash flow conversion, and net debt trajectory. These four signals, tracked together over five or more years, will tell you more about a business's future than any single earnings announcement.

Why Reported Earnings Mislead

Net income is constructed from dozens of accounting decisions: depreciation rates, revenue recognition timing, inventory valuation methods, capitalisation of expenses. All of these are set by management, audited but rarely second-guessed, and can be used legally to smooth earnings, shift timing, or obscure deterioration. Free cash flow—the actual cash generated after capital expenditures—is much harder to manipulate.

Metric #1: Organic Revenue Growth

Organic revenue growth is the revenue increase that comes from the core business—not from acquisitions, not from currency movements, but from selling more products or services to customers. A business that grows organically is demonstrating that customers value its offering enough to buy more of it, at prices that are at least keeping pace with the cost of delivering it.

The pattern to watch: organic growth declining over multiple years while total revenue holds flat means management is buying growth to hide the fact that the core business is contracting. A company growing organically at 7% a year is far healthier than one reporting 12% total growth, of which 5 percentage points come from an acquisition funded by issuing dilutive stock.

Metric #2: Gross Margin Trend

Gross profit margin is the most fundamental indicator of competitive pricing power. A company with stable or improving gross margins over five to ten years is demonstrating that it can hold or raise prices faster than its input costs rise. Terry Smith of Fundsmith uses gross margin stability as a core filter. His portfolio is concentrated in businesses with persistently high and stable gross margins: Microsoft (70%+), Novo Nordisk (85%+), L'Oréal (73%+). Declining gross margins tell you competitors are forcing price cuts, suppliers are raising costs the company can't pass along, or the product mix is shifting toward lower-margin offerings.

Metric #3: Free Cash Flow Conversion

Free cash flow conversion is the ratio of free cash flow to net income: FCF = Cash from Operations minus Capital Expenditures. FCF Conversion = FCF divided by Net Income. A healthy business converts 80–100%+ of net income into free cash flow consistently. Asset-light businesses—software companies, consumer brands, marketplaces—often exceed 100% FCF conversion because they receive cash from customers before recognising revenue. When FCF conversion is consistently below 60% of net income, something is wrong.

Metric #4: Net Debt Trajectory

Net debt—total borrowings minus cash and equivalents—tells you whether the business's financial resources are growing or shrinking over time. A genuinely healthy business should be able to pay down debt from operating cash flow. A business whose net debt is growing while organic revenue is flat or declining is funding operations, acquisitions, or dividends with borrowed money. Track the debt-to-EBITDA ratio over five years. For non-financial businesses, below 2x is comfortable; above 4x requires a clear explanation and a credible path to reduction.

The most dangerous pattern: net debt rising while organic revenue growth is decelerating and gross margins are declining. This combination means the business is borrowing to survive, not to invest. The most reassuring pattern: net debt declining year after year, driven by genuine operating cash generation, even while the business continues to invest in growth.

Reading the Vitals Together

Think of these four metrics as a patient's vital signs. Organic revenue growth is pulse rate. Gross margin trend is blood pressure. FCF conversion is blood oxygen. Net debt trajectory is the weight trend over time. Any one vital out of range is cause for concern. Multiple vitals deteriorating simultaneously is an emergency. The key is consistency—one bad quarter in FCF conversion might be a working capital timing issue. Four consecutive years of declining FCF conversion is a structural signal.

Building the Picture

A practical process for any company you're researching: (1) Pull five to ten years of annual reports or use a financial data site to access historical financials. (2) Build a simple table: Year, Organic Revenue Growth, Gross Margin, FCF Conversion, Net Debt/EBITDA. (3) Look for trends, not snapshots. Five years of directional movement tells you almost everything. (4) Flag any year where two or more metrics deteriorated simultaneously. (5) Read management's explanation for each deterioration — do they acknowledge root causes, or deflect to external factors?

The companies that pass this multi-year health check with consistency—organic growth holding or accelerating, margins stable or expanding, FCF conversion high, debt declining—are the building blocks of a quality portfolio. They may not always be cheap, but they're the businesses that compound wealth over decades.

The content on Gingernomics is for educational and informational purposes only and does not constitute financial advice. Always do your own research and consult a licensed financial advisor before making any investment decisions. Past performance is not indicative of future results.